These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3086223)

  • 1. How many class II immune response genes? A reappraisal of the evidence.
    Simpson E; Lieberman R; Andó I; Sachs DH; Paul WE; Berzofsky JA
    Immunogenetics; 1986; 23(5):302-8. PubMed ID: 3086223
    [No Abstract]   [Full Text] [Related]  

  • 2. How many class II immune response genes? A commentary on a reappraisal.
    Klein J
    Immunogenetics; 1986; 23(5):309-11. PubMed ID: 2940179
    [No Abstract]   [Full Text] [Related]  

  • 3. Responses against antigens encoded by the H-3 histocompatibility locus: antigens stimulating class I MHC- and class II MHC-restricted T cells are encoded by separate genes.
    Roopenian DC; Davis AP
    Immunogenetics; 1989; 30(5):335-43. PubMed ID: 2530167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective expression of antibody classes and contact sensitivity affected by genes in the major histocompatibility complex.
    Thomas WR; Watkins MC; Asherson GL
    Scand J Immunol; 1979; 9(1):23-8. PubMed ID: 105403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular genetics of the major histocompatibility complex].
    Witt M
    Postepy Biochem; 1985; 31(2):323-36. PubMed ID: 3938015
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of Igh-1 genes on the class and subclass distribution of oxazolone-specific antibodies.
    László G; Rajnavölgyi E; Andó I; Gergely J
    Immunogenetics; 1985; 21(5):429-43. PubMed ID: 3922883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunogenetics of the mouse major histocompatibility gene complex.
    Hansen TH; Spinella DG; Lee DR; Shreffler DC
    Annu Rev Genet; 1984; 18():99-129. PubMed ID: 6397127
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.
    Auchincloss H; Lee R; Shea S; Markowitz JS; Grusby MJ; Glimcher LH
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3373-7. PubMed ID: 8475083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene complementations generate hybrid Ia specificities involved in immune response.
    Lafuse WP; Yokota S; David CS
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1017-9. PubMed ID: 6168059
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune response genes controlling responsiveness to major transplantation antigens. Specific major histocompatibility complex-linked defect for antibody responses to class I alloantigens.
    Butcher GW; Corvalán JR; Licence DR; Howard JC
    J Exp Med; 1982 Jan; 155(1):303-20. PubMed ID: 6172542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic control of two different types of antibody responses to oxazolone.
    Andó I; Fachet J
    Eur J Immunol; 1977 Aug; 7(8):516-9. PubMed ID: 902679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An introduction to immunobiology - III. immunogenetics (third of three parts).
    Ablin RJ
    Allergol Immunopathol (Madr); 1978; 6(6):541-4. PubMed ID: 110122
    [No Abstract]   [Full Text] [Related]  

  • 14. I-J alternates--a commentary.
    Tada T; Uracz W
    J Mol Cell Immunol; 1985; 2(2):104-5. PubMed ID: 3939780
    [No Abstract]   [Full Text] [Related]  

  • 15. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.
    Itescu S; Tung TC; Burke EM; Weinberg A; Moazami N; Artrip JH; Suciu-Foca N; Rose EA; Oz MC; Michler RE
    Circulation; 1998 Aug; 98(8):786-93. PubMed ID: 9727549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic control of the immune response to myoglobins. VI. Distinct Ir genes for different myoglobins: complementing genes in I-A and H-2D for equine myoglobin.
    Berzofsky JA; Buckenmeyer GK; Hicks G
    J Immunol; 1982 Feb; 128(2):737-41. PubMed ID: 6798122
    [No Abstract]   [Full Text] [Related]  

  • 17. MHC-linked and non-MHC-linked immune response genes in the rat.
    Davis BK; Kunz HW; Shonnard JW; Gill TJ
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1046-8. PubMed ID: 6168062
    [No Abstract]   [Full Text] [Related]  

  • 18. B-L antigens (Ia-like antigens) of the chicken major histocompatibility complex.
    Crone M; Jensenius JC; Koch C
    Scand J Immunol; 1981 Dec; 14(6):591-7. PubMed ID: 6210953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hapten-specific Ir gene.
    Pelkonen JL; Kaartinen M; Karjalainen K; Mäkelä O
    J Immunol; 1979 Oct; 123(4):1558-64. PubMed ID: 90089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex.
    Hattori M; Buse JB; Jackson RA; Glimcher L; Dorf ME; Minami M; Makino S; Moriwaki K; Kuzuya H; Imura H
    Science; 1986 Feb; 231(4739):733-5. PubMed ID: 3003909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.